364 related articles for article (PubMed ID: 18945226)
1. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
[TBL] [Abstract][Full Text] [Related]
2. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
[TBL] [Abstract][Full Text] [Related]
5. Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder.
Simpson TL; Saxon AJ; Stappenbeck C; Malte CA; Lyons R; Tell D; Millard SP; Raskind M
Am J Psychiatry; 2018 Dec; 175(12):1216-1224. PubMed ID: 30153753
[TBL] [Abstract][Full Text] [Related]
6. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
[TBL] [Abstract][Full Text] [Related]
9. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
Marra D; Warot D; Berlin I; Hispard E; Notides C; Tilikete S; Payan C; Lépine JP; Dally S; Aubin HJ
Alcohol Clin Exp Res; 2002 Oct; 26(10):1545-52. PubMed ID: 12394288
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dexfenfluramine in the treatment of alcohol dependence.
Romach MK; Sellers EM; Kaplan HL; Somer GR; Gomez-Mancilla B
Alcohol Clin Exp Res; 2000 Oct; 24(10):1534-41. PubMed ID: 11045862
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms.
Lepor H; Theune C
J Urol; 1995 Jul; 154(1):116-8. PubMed ID: 7776406
[TBL] [Abstract][Full Text] [Related]
13. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
[TBL] [Abstract][Full Text] [Related]
14. The effect of telephone-based intervention (TBI) in alcohol abusers: a pilot study.
Wongpakaran T; Petcharaj K; Wongpakaran N; Sombatmai S; Boripuntakul T; Intarakamhaeng D; Wannarit K
J Med Assoc Thai; 2011 Jul; 94(7):849-56. PubMed ID: 21774293
[TBL] [Abstract][Full Text] [Related]
15. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.
Mueller TI; Stout RL; Rudden S; Brown RA; Gordon A; Solomon DA; Recupero PR
Alcohol Clin Exp Res; 1997 Feb; 21(1):86-92. PubMed ID: 9046378
[TBL] [Abstract][Full Text] [Related]
17. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
[TBL] [Abstract][Full Text] [Related]
18. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
19. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.
Low BY; Liong ML; Yuen KH; Chee C; Leong WS; Chong WL; Khan NA; Cheah PY; Liong KK
J Urol; 2008 Apr; 179(4):1461-9. PubMed ID: 18295277
[TBL] [Abstract][Full Text] [Related]
20. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
Wong CJ; Witcher J; Mallinckrodt C; Dean RA; Anton RF; Chen Y; Fijal BA; Ouyang H; Dharia S; Sundseth SS; Schuh KJ; Kinon BJ
Alcohol Clin Exp Res; 2014 Feb; 38(2):511-20. PubMed ID: 24010675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
